The researchers estimated that the number of people living with Parkinson’s disease around the world would hit 25.2 million ...

Harvard's PDGrapher AI tool forecasts gene-drug pairings that restore diseased cells, marking a breakthrough in precision ...

A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects. The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness, coordination, ...

The venture arms of Merck KGaA and Novartis are among the investors involved in raising $67 million for NRG Therapeutics, ...

One month of daily bright light therapy significantly improved visual function in patients with Parkinson’s disease and ...

The Food and Drug Administration approved Adamas Pharmaceuticals’ drug Gocovri to treat dyskinesia, a side effect of a medication prescribed to most Parkinson’s disease patients, reports Reuters. Here ...

Benztropine, a drug prescribed for tremors in Parkinson’s disease, has shown promise against tuberculosis (TB) in both human cell and mouse models. The corresponding study was published in npj ...

Jan. 14 -- WEDNESDAY, Jan. 13 (HealthDay News) -- Reduced dosages of dopamine agonists, drugs routinely used to treat Parkinson's disease, can cause symptoms similar to those experienced by addicts in ...

Austin nonprofit Power for Parkinson's has found new audiences among English and Spanish speakers around the world through ...